Note: Ingredients listed on restricted chemical lists
EC/CAS
247-852-1/26628-22-8
Name of the chemical
Sodium Azide
Concentration
1.3%
General Information
Revision date
2015-07-17
Product name
CEDIA Digitoxin Assay
Product Synonyms
CEDIA® Digitoxin Assay - High and Low Calibrators for 100004, CEDIA® Digitoxin Assay
CAS No.
26628-22-8
1.2.1 Relevant identified uses
In vitro diagnostic kit
Emergency telephone
(24-hour availability
Icons in SDS
Company Information
company name
Microgenics Corporation
e-mail address of the competent person responsible for the Safety Data Sheet
techservice.mgc@thermofisher.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H412
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
2.1 Classification of the substance or mixture
Globally Harmonized Acute Toxicity (Oral) Category 4. Aquatic toxicity (chronic) - Category 3. System [GHS] Other/Supplemental Mixture not yet fully tested.
2.2 Label elements
SECTION 2 - HAZARDS IDENTIFICATION …continued
Signal word
Warning
Hazard statements
H302 - Harmful if swallowed. H412 - Harmful to aquatic life with long lasting effects. EUH032 - Contact with acids liberates very toxic gas when using this product. P273 - Avoid release to the environment. P301+P312: IF SWALLOWED: Call a Poison Center or doctor/physician if you feel unwell. P330 - Rinse mouth. P501 - Dispose of contents/container to location in accordance with local/regional/national/international regulations.
Precautionary statements
P264 - Wash hands thoroughly after handling. P270 - Do not eat, drink or smoke
2.3 Other hazards
The potential health hazards associated with exposure/handling of this mixture are unknown; no data specific for the mixture were identified. The following data describe the hazards of individual ingredients, where applicable. This product/mixture contains human source material (human serum) and should be treated/handled as a potential biohazard. All such human serum has been derived from donors tested individually and shown by FDA approved methods to be free from antibodies to Human Immune Deficiency Virus and Hepatitis B and C. As no test method can offer complete assurance that these or other infectious agents are not present, this product should be handled using standard biosafety precautions. Note This mixture is classified as hazardous according to Regulation EC No 1272/2008 (EU CLP) and Hazard Communication Standard No. 1910.1200 (US OSHA). The pharmacological, toxicological and ecological properties of this mixture have not been fully characterized.
